,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2017-02-27 23:00:00,The following companies are expected to report earnings after hours on 02/28/2017.,0.010730791836977005,0.014338824898004532,0.9749303460121155,neutral,-0.003608033061027527
1,2017-02-27 23:00:00,Visit our Earnings Calendar for a full list of expected earnings releases.,0.012093440629541874,0.010449538938701153,0.9774569869041443,neutral,0.0016439016908407211
2,2017-02-27 23:00:00,"Salesforce.com Inc ( CRM ) is reporting for the quarter ending January 31, 2017.",0.016391117125749588,0.016667533665895462,0.9669413566589355,neutral,-0.000276416540145874
3,2017-02-27 23:00:00,The computer software company's consensus earnings per share forecast from the 13 analysts that follow the stock is $0.04.,0.11812186241149902,0.10591724514961243,0.7759609222412109,neutral,0.012204617261886597
4,2017-02-27 23:00:00,This value represents a 300.00% increase compared to the same quarter last year.,0.9519718289375305,0.02223808318376541,0.025790158659219742,positive,0.9297337532043457
5,2017-02-27 23:00:00,CRM missed the consensus earnings per share in the 1st calendar quarter of 2016 by -75%.,0.021159401163458824,0.9632294178009033,0.015611170791089535,negative,-0.9420700073242188
6,2017-02-27 23:00:00,"Zacks Investment Research reports that the 2017 Price to Earnings ratio for CRM is 354.52 vs. an industry ratio of 62.10, implying that they will have a higher earnings growth than their competitors in the same industry.",0.9013040661811829,0.06387300044298172,0.034822966903448105,positive,0.8374310731887817
7,2017-02-27 23:00:00,"Ross Stores, Inc. ( ROST ) is reporting for the quarter ending January 31, 2017.",0.016377100721001625,0.01492100115865469,0.9687018990516663,neutral,0.0014560995623469353
8,2017-02-27 23:00:00,The discount retail company's consensus earnings per share forecast from the 11 analysts that follow the stock is $0.75.,0.07724468410015106,0.03765818849205971,0.8850971460342407,neutral,0.039586495608091354
9,2017-02-27 23:00:00,This value represents a 13.64% increase compared to the same quarter last year.,0.9489815831184387,0.02346736751496792,0.02755102701485157,positive,0.9255142211914062
10,2017-02-27 23:00:00,In the past year ROST has met analyst expectations once and beat the expectations the other three quarters.,0.946759819984436,0.024264199659228325,0.02897598035633564,positive,0.9224956035614014
11,2017-02-27 23:00:00,"Zacks Investment Research reports that the 2017 Price to Earnings ratio for ROST is 24.61 vs. an industry ratio of 15.70, implying that they will have a higher earnings growth than their competitors in the same industry.",0.8907215595245361,0.07364615052938461,0.03563234210014343,positive,0.8170754313468933
12,2017-02-27 23:00:00,"Palo Alto Networks, Inc. ( PANW ) is reporting for the quarter ending January 31, 2017.",0.015175140462815762,0.014864109456539154,0.9699608087539673,neutral,0.0003110310062766075
13,2017-02-27 23:00:00,The information technology services company's consensus earnings per share forecast from the 5 analysts that follow the stock is $-0.38.,0.0909959077835083,0.06889434158802032,0.8401097059249878,neutral,0.022101566195487976
14,2017-02-27 23:00:00,This value represents a 54.22% increase compared to the same quarter last year.,0.9484668374061584,0.023586763069033623,0.027946418151259422,positive,0.9248800873756409
15,2017-02-27 23:00:00,Zacks Investment Research reports that the 2017 Price to Earnings ratio for PANW is -148.03 vs. an industry ratio of 9.50.,0.43658483028411865,0.3517898917198181,0.21162530779838562,positive,0.08479493856430054
16,2017-02-27 23:00:00,"Universal Health Services, Inc. ( UHS ) is reporting for the quarter ending December 31, 2016.",0.01625640131533146,0.01536419428884983,0.9683794379234314,neutral,0.0008922070264816284
17,2017-02-27 23:00:00,The hospital company's consensus earnings per share forecast from the 6 analysts that follow the stock is $1.79.,0.06585568189620972,0.024291422218084335,0.9098528623580933,neutral,0.04156425967812538
18,2017-02-27 23:00:00,This value represents a 4.68% increase compared to the same quarter last year.,0.9492922425270081,0.023441672325134277,0.027266070246696472,positive,0.9258505702018738
19,2017-02-27 23:00:00,"Zacks Investment Research reports that the 2016 Price to Earnings ratio for UHS is 17.28 vs. an industry ratio of 13.20, implying that they will have a higher earnings growth than their competitors in the same industry.",0.9037497639656067,0.05778514966368675,0.038465071469545364,positive,0.8459646105766296
20,2017-02-27 23:00:00,"TESARO, Inc. ( TSRO ) is reporting for the quarter ending December 31, 2016.",0.01575869880616665,0.013227340765297413,0.9710139632225037,neutral,0.002531358040869236
21,2017-02-27 23:00:00,The drug company's consensus earnings per share forecast from the 12 analysts that follow the stock is $-1.96.,0.05886072665452957,0.020236674696207047,0.9209026098251343,neutral,0.038624051958322525
22,2017-02-27 23:00:00,This value represents a 3.70% decrease compared to the same quarter last year.,0.01998939737677574,0.9712680578231812,0.008742542006075382,negative,-0.9512786865234375
23,2017-02-27 23:00:00,Zacks Investment Research reports that the 2016 Price to Earnings ratio for TSRO is -25.29 vs. an industry ratio of 6.60.,0.45205196738243103,0.2030377835035324,0.34491029381752014,positive,0.24901418387889862
24,2017-02-27 23:00:00,"Jazz Pharmaceuticals plc ( JAZZ ) is reporting for the quarter ending December 31, 2016.",0.01832466386258602,0.012274532578885555,0.9694008231163025,neutral,0.006050131283700466
25,2017-02-27 23:00:00,The drug company's consensus earnings per share forecast from the 3 analysts that follow the stock is $1.65.,0.05517464876174927,0.021882034838199615,0.9229433536529541,neutral,0.03329261392354965
26,2017-02-27 23:00:00,This value represents a 27.31% decrease compared to the same quarter last year.,0.019938021898269653,0.9714543223381042,0.00860764179378748,negative,-0.9515162706375122
27,2017-02-27 23:00:00,In the past year JAZZ has beat the expectations every quarter.,0.8923052549362183,0.041064344346523285,0.06663038581609726,positive,0.8512409329414368
28,2017-02-27 23:00:00,The highest one was in the 3rd calendar quarter where they beat the consensus by 37.58%.,0.8267959356307983,0.054903943091630936,0.11830010265111923,positive,0.7718920111656189
29,2017-02-27 23:00:00,"Zacks Investment Research reports that the 2016 Price to Earnings ratio for JAZZ is 22.38 vs. an industry ratio of 6.60, implying that they will have a higher earnings growth than their competitors in the same industry.",0.9012276530265808,0.0583680085837841,0.04040435701608658,positive,0.8428596258163452
30,2017-02-27 23:00:00,"Antero Resources Corporation ( AR ) is reporting for the quarter ending December 31, 2016.",0.013883676379919052,0.012649709358811378,0.9734665751457214,neutral,0.0012339670211076736
31,2017-02-27 23:00:00,The oil (us exp & production) company's consensus earnings per share forecast from the 9 analysts that follow the stock is $0.13.,0.11109492927789688,0.09225516766309738,0.7966499328613281,neutral,0.0188397616147995
32,2017-02-27 23:00:00,This value represents a no change for the same quarter last year.,0.13893510401248932,0.05664924904704094,0.8044156432151794,neutral,0.08228585124015808
33,2017-02-27 23:00:00,In the past year AR has beat the expectations every quarter.,0.9192044138908386,0.03765714168548584,0.043138474225997925,positive,0.8815472722053528
34,2017-02-27 23:00:00,The highest one was in the 3rd calendar quarter where they beat the consensus by 200%.,0.8163388967514038,0.05934621021151543,0.12431486696004868,positive,0.7569926977157593
35,2017-02-27 23:00:00,"Zacks Investment Research reports that the 2016 Price to Earnings ratio for AR is 67.00 vs. an industry ratio of -8.80, implying that they will have a higher earnings growth than their competitors in the same industry.",0.9155825972557068,0.05289435014128685,0.03152310848236084,positive,0.8626882433891296
36,2017-02-27 23:00:00,"DexCom, Inc. ( DXCM ) is reporting for the quarter ending December 31, 2016.",0.016561705619096756,0.013892916962504387,0.969545304775238,neutral,0.002668788656592369
37,2017-02-27 23:00:00,The medical instruments company's consensus earnings per share forecast from the 14 analysts that follow the stock is $-0.10.,0.0818653553724289,0.062436074018478394,0.8556985259056091,neutral,0.0194292813539505
38,2017-02-27 23:00:00,This value represents a 600.00% decrease compared to the same quarter last year.,0.019731365144252777,0.9714534282684326,0.008815203793346882,negative,-0.9517220854759216
39,2017-02-27 23:00:00,Zacks Investment Research reports that the 2016 Price to Earnings ratio for DXCM is -100.27 vs. an industry ratio of 3.40.,0.5988072156906128,0.14057430624961853,0.26061853766441345,positive,0.45823290944099426
40,2017-02-27 23:00:00,"EPR Properties ( EPR ) is reporting for the quarter ending December 31, 2016.",0.01423747930675745,0.012770276516675949,0.9729922413825989,neutral,0.001467202790081501
41,2017-02-27 23:00:00,The reit company's consensus earnings per share forecast from the 5 analysts that follow the stock is $1.23.,0.08254081010818481,0.025097673758864403,0.8923615217208862,neutral,0.05744313448667526
42,2017-02-27 23:00:00,This value represents a 4.24% increase compared to the same quarter last year.,0.9495862722396851,0.023662274703383446,0.02675144374370575,positive,0.9259240031242371
43,2017-02-27 23:00:00,In the past year EPR has met analyst expectations once and beat the expectations the other three quarters.,0.950846254825592,0.023561200127005577,0.02559257671236992,positive,0.9272850751876831
44,2017-02-27 23:00:00,Zacks Investment Research reports that the 2016 Price to Earnings ratio for EPR is 16.16 vs. an industry ratio of 16.50.,0.520717978477478,0.2300945520401001,0.24918749928474426,positive,0.29062342643737793
45,2017-02-27 23:00:00,"LogMein, Inc. ( LOGM ) is reporting for the quarter ending December 31, 2016.",0.017003778368234634,0.013721293769776821,0.9692748785018921,neutral,0.0032824845984578133
46,2017-02-27 23:00:00,The computer services company's consensus earnings per share forecast from the 4 analysts that follow the stock is $0.36.,0.07200869172811508,0.09483937174081802,0.8331518769264221,neutral,-0.022830680012702942
47,2017-02-27 23:00:00,This value represents a 2.86% increase compared to the same quarter last year.,0.9480851292610168,0.024627311155200005,0.02728760987520218,positive,0.9234578013420105
48,2017-02-27 23:00:00,In the past year LOGM has beat the expectations every quarter.,0.9433420896530151,0.02674611285328865,0.02991177700459957,positive,0.916595995426178
49,2017-02-27 23:00:00,The highest one was in the 3rd calendar quarter where they beat the consensus by 14.29%.,0.8274841904640198,0.05650957301259041,0.11600624769926071,positive,0.7709746360778809
50,2017-02-27 23:00:00,"Zacks Investment Research reports that the 2016 Price to Earnings ratio for LOGM is 90.14 vs. an industry ratio of 26.40, implying that they will have a higher earnings growth than their competitors in the same industry.",0.9084908962249756,0.05817358195781708,0.03333555907011032,positive,0.8503172993659973
51,2017-02-27 23:00:00,"ACADIA Pharmaceuticals Inc. ( ACAD ) is reporting for the quarter ending December 31, 2016.",0.01699758507311344,0.013018128462135792,0.969984233379364,neutral,0.00397945661097765
52,2017-02-27 23:00:00,The biomedical (gene) company's consensus earnings per share forecast from the 7 analysts that follow the stock is $-0.65.,0.08100868761539459,0.047062087804079056,0.8719292283058167,neutral,0.033946599811315536
53,2017-02-27 23:00:00,This value represents a 44.44% decrease compared to the same quarter last year.,0.020150141790509224,0.9712753295898438,0.00857445877045393,negative,-0.9511252045631409
54,2017-02-27 23:00:00,Zacks Investment Research reports that the 2016 Price to Earnings ratio for ACAD is -17.25 vs. an industry ratio of -3.10.,0.4139952063560486,0.13580606877803802,0.45019879937171936,neutral,0.27818912267684937
55,2017-02-27 23:00:00,"Blue Buffalo Pet Products, Inc. ( BUFF ) is reporting for the quarter ending December 31, 2016.",0.0190126933157444,0.01172681525349617,0.9692604541778564,neutral,0.00728587806224823
56,2017-02-27 23:00:00,The consumer company's consensus earnings per share forecast from the 6 analysts that follow the stock is $0.18.,0.05855659395456314,0.04369892552495003,0.8977444767951965,neutral,0.014857668429613113
57,2017-02-27 23:00:00,This value represents a 12.50% increase compared to the same quarter last year.,0.9499266147613525,0.022601282224059105,0.027472183108329773,positive,0.9273253083229065
58,2017-02-27 23:00:00,In the past year BUFF has beat the expectations every quarter.,0.891147255897522,0.05110812187194824,0.05774461850523949,positive,0.8400391340255737
59,2017-02-27 23:00:00,The highest one was in the 3rd calendar quarter where they beat the consensus by 10%.,0.8308614492416382,0.06188229098916054,0.10725625604391098,positive,0.7689791321754456
60,2017-02-27 23:00:00,"The ""days to cover"" for this stock exceeds 12 days.",0.016237454488873482,0.00841823872178793,0.9753443598747253,neutral,0.007819215767085552
61,2017-02-27 23:00:00,"Zacks Investment Research reports that the 2016 Price to Earnings ratio for BUFF is 31.01 vs. an industry ratio of -5.60, implying that they will have a higher earnings growth than their competitors in the same industry.",0.8855569958686829,0.0746433436870575,0.03979972377419472,positive,0.8109136819839478
62,2017-02-27 23:00:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
